These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34736988)

  • 21. Physalis Mottle Virus-Like Particles as Nanocarriers for Imaging Reagents and Drugs.
    Masarapu H; Patel BK; Chariou PL; Hu H; Gulati NM; Carpenter BL; Ghiladi RA; Shukla S; Steinmetz NF
    Biomacromolecules; 2017 Dec; 18(12):4141-4153. PubMed ID: 29144726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibronectin-binding nanoparticles for intracellular targeting addressed by B. burgdorferi BBK32 protein fragments.
    Ranka R; Petrovskis I; Sominskaya I; Bogans J; Bruvere R; Akopjana I; Ose V; Timofejeva I; Brangulis K; Pumpens P; Baumanis V
    Nanomedicine; 2013 Jan; 9(1):65-73. PubMed ID: 22633898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Common and Distinct Capsid and Surface Protein Requirements for Secretion of Complete and Genome-Free Hepatitis B Virions.
    Ning X; Luckenbaugh L; Liu K; Bruss V; Sureau C; Hu J
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human parvovirus B19 virus-like particles: In vitro assembly and stability.
    Sánchez-Rodríguez SP; Münch-Anguiano L; Echeverría O; Vázquez-Nin G; Mora-Pale M; Dordick JS; Bustos-Jaimes I
    Biochimie; 2012 Mar; 94(3):870-8. PubMed ID: 22192916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Rous sarcoma Virus-like Particles Displaying hCC49 scFv for Specific Targeted Drug Delivery to Human Colon Carcinoma Cells.
    Kato T; Yui M; Deo VK; Park EY
    Pharm Res; 2015 Nov; 32(11):3699-707. PubMed ID: 26047779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decoration of virus-like particles with an enzymatic activity of biomedical interest.
    Cayetano-Cruz M; Coffeen CF; Valadez-García J; Montiel C; Bustos-Jaimes I
    Virus Res; 2018 Aug; 255():1-9. PubMed ID: 29964063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient Production of Chimeric Hepatitis B Virus-Like Particles Bearing an Epitope of Hepatitis E Virus Capsid by Transient Expression in
    Zahmanova G; Mazalovska M; Takova K; Toneva V; Minkov I; Peyret H; Lomonossoff G
    Life (Basel); 2021 Jan; 11(1):. PubMed ID: 33477348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineering Virus-like Particles for Antigen and Drug Delivery.
    Hill BD; Zak A; Khera E; Wen F
    Curr Protein Pept Sci; 2018; 19(1):112-127. PubMed ID: 27875963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly efficient production of phosphorylated hepatitis B core particles in yeast Pichia pastoris.
    Freivalds J; Dislers A; Ose V; Pumpens P; Tars K; Kazaks A
    Protein Expr Purif; 2011 Feb; 75(2):218-24. PubMed ID: 20854910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetically engineered fusion of allergen and viral-like particle induces a more effective allergen-specific immune response than a combination of them.
    Sani MZ; Bargahi A; Momenzadeh N; Dehghani P; Moghadam MV; Maleki SJ; Nabipour I; Shirkani A; Akhtari J; Hesamizadeh K; Heidari S; Omrani F; Akbarzadeh S; Mohammadi M
    Appl Microbiol Biotechnol; 2021 Jan; 105(1):77-91. PubMed ID: 33215260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chimeric Virus-Like Particles of Prawn Nodavirus Displaying Hepatitis B Virus Immunodominant Region: Biophysical Properties and Cytokine Response.
    Ninyio NN; Ho KL; Yong CY; Chee HY; Hamid M; Ong HK; Mariatulqabtiah AR; Tan WS
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide.
    Schumacher J; Bacic T; Staritzbichler R; Daneschdar M; Klamp T; Arnold P; Jägle S; Türeci Ö; Markl J; Sahin U
    J Nanobiotechnology; 2018 Apr; 16(1):39. PubMed ID: 29653575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of HBs, HBc, and frCP virus-like particles for expression of human papillomavirus 16 E7 oncoprotein epitopes.
    Pumpens P; Razanskas R; Pushko P; Renhof R; Gusars I; Skrastina D; Ose V; Borisova G; Sominskaya I; Petrovskis I; Jansons J; Sasnauskas K
    Intervirology; 2002; 45(1):24-32. PubMed ID: 11937768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods.
    Chen CC; Stark M; Baikoghli M; Cheng RH
    J Vis Exp; 2018 May; (135):. PubMed ID: 29806824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virus Like Particles as Immunogens and Universal Nanocarriers.
    Naskalska A; Pyrć K
    Pol J Microbiol; 2015; 64(1):3-13. PubMed ID: 26094310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The application of virus-like particles as vaccines and biological vehicles.
    Yan D; Wei YQ; Guo HC; Sun SQ
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10415-32. PubMed ID: 26454868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HBV core particles as a carrier for B cell/T cell epitopes.
    Pumpens P; Grens E
    Intervirology; 2001; 44(2-3):98-114. PubMed ID: 11509871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly modular hepatitis B virus-like nanocarriers for therapeutic protein encapsulation and targeted delivery to triple negative breast cancer cells.
    Yur D; Sullivan MO; Chen W
    J Mater Chem B; 2023 May; 11(18):3985-3993. PubMed ID: 37083736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity.
    Hyakumura M; Walsh R; Thaysen-Andersen M; Kingston NJ; La M; Lu L; Lovrecz G; Packer NH; Locarnini S; Netter HJ
    J Virol; 2015 Nov; 89(22):11312-22. PubMed ID: 26339047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide presentation on primate erythroparvovirus 1 virus-like particles: In vitro assembly, stability and immunological properties.
    Del Carmen Morán-García A; Rivera-Toledo E; Echeverría O; Vázquez-Nin G; Gómez B; Bustos-Jaimes I
    Virus Res; 2016 Sep; 224():12-8. PubMed ID: 27523978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.